Your trusted source for investing success since 2007. Renowned for our market outlook reports and investing guides.
Relevium Technologies
Global Brands for the Nutraceutical and Wellness Markets
Overview
Relevium Technologies Inc. (TSXV:RLV,OTCQB:RLLVF,FWB:6BX) is a wellness portfolio company that currently operates through two wholly-owned subsidiaries: BGX e-Health and Biocannabix Health Corporation.
BGX e-Health LLC, based in Orlando, Florida seeks to acquire and operate e-retail brands in the health and wellness space in order to build a portfolio which it can innovate through the introduction of high growth and trending products.
The company currently operates through three major brands: Bioganix®, PushandPullsystem® and LeefyLyfe®, which on a combined basis offer a variety of health, skincare and fitness supplements for the health and wellness market. The subsidiary generates over $1 million in revenue per quarter and has a well-defined distribution network throughout the US that includes large online retailers such as Amazon (NASDAQ:AMZN) and Walmart (NYSE:WMT). In total, the company has 58 SKUs under the BioGanix brand as well as an aloe vera-based brand of anti-aging cosmeceutical products that target Hispanic women in the US.
Relevium Technologies’ Company Highlights
- Relevium operates in the CPG health and wellness market, which in 2017 reached $4.2 trillion.
- Global cannabinoid market is expected to surpass $31 billion by 2021.
- Global nutraceutical market to reach US$578.23 billion by 2025.
- Vast distribution network through industry giants like Walmart and Amazon.
- Relevium signed an agreement to acquire a late-stage applicant for standard processing and medical sales license in Canada, facilitating the company’s entrance into Canada.
- Lifeline acquisition is expected to provide Relevium with an EU-GMP extraction facility, up to six million-square-feet of cultivation space and three licenses with scientific research, domestic sales and export capabilities.
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.Â